Longevity Without Hype

Doctor Alo, if you disagree with Paul about saturated fat, then address the evidence instead of repeatedly calling him a “moron,” mocking his pronunciation and dismissing him because he is a psychiatrist. Being a psychiatrist does not prevent a physician from reading and understanding the same published research on nutrition, LDL and cardiovascular disease that a cardiologist reads. Your repeated message of “saturated fat bad, LDL bad” also strips away important context. Saturated fat can raise LDL cholesterol, particularly when it replaces unsaturated fat in the diet. That is well established. But that does not mean every animal food containing saturated fat is therefore unhealthy, nor does an animal based food become “bad” because one of its fatty acids is saturated. Meat, eggs and dairy are whole foods containing different mixtures of saturated, monounsaturated and polyunsaturated fats along with protein and important micronutrients. The amount eaten, the specific food, what replaces it, the person’s overall diet, metabolic health, genetics, physical activity and other cardiovascular risk factors all matter.
We even have traditional populations demonstrating why this cannot be reduced to a three word slogan. Historical studies of the Maasai documented diets containing large amounts of animal foods and very high amounts of dietary fat while finding relatively low serum cholesterol. That does not prove unlimited saturated fat is harmless. It does demonstrate that eating animal foods and saturated fat does not automatically translate into the simplistic sequence you keep presenting.
And dismissing Paul because he is a psychiatrist is particularly strange when you are a cardiologist who publishes nutrition advice and even writes cookbooks. If physicians are allowed to discuss evidence outside the narrowest boundaries of their specialty, that principle applies to both of you. If Paul has the science wrong, show precisely what he got wrong and provide the evidence. Calling another physician an idiot or a moron is not evidence. The research should settle the argument, not the specialty printed after someone’s name.
Paul Saladino MD

“THE TIMELINE MATTERS: HEART DISEASE DEATHS WERE PLUMMETING BEFORE STATINS”☑️🇨🇦❤️

Watch this video carefully and pay attention to the dates. In 1969, the age adjusted U.S. heart disease death rate was 512.4 per 100,000. By 1987, when the first statin was approved in the United States, it had already fallen to 349.7. That is almost a 32% decline before statins were even available. Statins were still used by only a small percentage of Americans for years afterward, while heart disease mortality continued a decline that had begun decades earlier.

That history matters because lowering an LDL number on a blood test and proving that a medication meaningfully extends a person’s life are not the same thing. The decline in heart disease deaths began long before statins. Smoking fell dramatically. Blood pressure detection and treatment improved. Emergency medicine, coronary care units, CPR and defibrillation improved. Heart attacks became much more survivable. Bypass surgery, angioplasty, stents and secondary prevention changed cardiovascular medicine.

Now look at what the randomized statin evidence actually shows in people without established cardiovascular disease. The 2022 systematic review for the U.S. Preventive Services Task Force pooled 18 trials involving more than 85,000 people for all cause mortality. Over 1 to 6 years, the absolute difference in deaths was just 0.35 percentage points, about 3.5 fewer deaths for every 1,000 people treated. The reduction in cardiovascular mortality itself did not reach statistical significance. Statins did reduce nonfatal heart attacks and strokes, and those benefits become more important as a person’s underlying cardiovascular risk rises. But that is very different from claiming that taking a statin means you will live substantially longer.

Another analysis asked a much more understandable question: how much longer did people actually survive during the randomized statin trials? Across the primary prevention trials examined, the median postponement of death was only 3.2 days during trials lasting approximately 2 to 6 years. The authors correctly cautioned that this does not tell us what the lifetime effect of taking a statin for decades might be.

None of this means cholesterol or ApoB containing particles are irrelevant, and it does not mean statins never prevent cardiovascular events. It means we should stop confusing three completely different claims: lowering LDL, reducing the probability of a cardiovascular event, and actually extending someone’s life by a meaningful amount.

Your overall cardiovascular risk still matters enormously: smoking, blood pressure, diabetes and metabolic health, physical activity, body composition, diet, genetics, ApoB, Lp(a), existing plaque and age. A pill that lowers LDL does not erase those factors, and a healthy lifestyle does not become irrelevant because someone’s LDL number changed.

This video makes one historical fact impossible to miss: America’s enormous decline in heart disease mortality was already well underway before statins existed. Statins cannot be credited with causing a decline that started decades before they arrived.☑️🇨🇦❤️

https://jamanetwork.com/journals/jama/fullarticle/2795522

https://bmjopen.bmj.com/content/5/9/e007118

~ Dale R. Reynolds

Dan, you keep repeating the same Blue Zones alcohol claim as though it proves something that the evidence does not prove. The entire argument starts with selecting people who reached extreme old age and then looking backward at what some of them did. If some centenarians drank alcohol, that proves only that some people who drank alcohol survived to 100. It does not prove that alcohol helped them get there. The people who drank alcohol and died at 55, 65, 75 or 85 are not standing there being interviewed as Blue Zone centenarians. That is exactly why you cannot establish causation this way.
There is another problem. The exceptional longevity records underlying the Blue Zone story have themselves been seriously challenged by demographic research. Saul Newman found extraordinary age records associated with poor birth registration, clerical errors and patterns consistent with pension fraud. His analysis found that introducing birth certificates in U.S. states was associated with a 69–82% decline in recorded supercentenarians. Blue Zone researchers dispute his conclusions, but the underlying longevity claims are clearly not the unquestionable evidence they are marketed as.

Then look at the alcohol evidence itself. A meta analysis of 107 studies published in JAMA Network Open found no significant reduction in all cause mortality from occasional or low volume drinking after correcting for important biases. The WHO states that alcohol is toxic, carcinogenic and that even low levels carry health risks. So “many Blue Zone centenarians drank alcohol” is not evidence that alcohol promotes longevity. It is an observation taken from a selected group of survivors, built on longevity data that is itself under serious scientific dispute. You cannot turn that into evidence that drinking alcohol helps people live longer.

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2802963

https://www.who.int/news-room/fact-sheets/detail/alcohol

https://www.biorxiv.org/content/10.1101/704080v3

Dr. Alo, here we go again on spreading misinformation, and you are still displaying the same chart, declaring that LDL kills and claiming that the 2017 Ference paper examined every single study ever conducted on LDL cholesterol. That is not what the paper says. It reviewed multiple categories of evidence involving more than 2 million participants and over 20 million person years of follow up. It did not examine every LDL study ever published, nor did every study demonstrate reductions in cardiovascular events and all cause mortality. You are taking evidence supporting the causal role of LDL particles in atherosclerosis and presenting it as though it settles every question about individual cardiovascular risk, ApoB, statin treatment and mortality. It does not. You have also recently started including ApoB in your explanations, yet this video returns to your previous message that LDL cholesterol alone tells the story. Are you now acknowledging that LDL cholesterol and ApoB are different measurements that can provide different information about cardiovascular risk? And can you identify where the 2017 paper establishes that every person with elevated LDL cholesterol requires statin treatment, regardless of their ApoB level and overall cardiovascular risk? Please address what the research actually demonstrates rather than repeating the same chart and directing people to your website. The original paper is available here: https://doi.org/10.1093/eurheartj/ehx144

You keep throwing around 20 million person years of follow up as though that number alone proves everything you are saying. It doesn't. You also keep changing your message. In your previous videos, with that same chart behind you, you focused on LDL cholesterol. Now you are bringing ApoB into the discussion as though you have been explaining the distinction all along. LDL cholesterol and ApoB are not interchangeable measurements. LDL cholesterol measures the amount of cholesterol carried in LDL particles, while ApoB provides a measure of the number of atherogenic lipoprotein particles. That distinction matters, especially when the two measurements do not agree. Why weren't you explaining this in your earlier videos instead of repeatedly focusing on LDL cholesterol alone?
And let's get your numbers straight. The 2017 paper by Brian Ference and colleagues reviewed evidence from more than 200 studies involving over 2 million participants, 20 million person years of follow up and 150,000 cardiovascular events. That is a combined body of evidence, not one study that followed people for 20 million years. The paper supports a causal role for LDL particles in atherosclerotic cardiovascular disease. It also recognizes that LDL cholesterol and particle number can differ. Why are you presenting this as though one cholesterol measurement tells the entire story? The study does not establish that every person with elevated LDL cholesterol has the same cardiovascular risk or that every person requires the same treatment. Individual risk assessment still matters.
https://academic.oup.com/eurheartj/article/38/32/2459/3745109
And why are you calling people severely misinformed or questioning their intelligence simply because they ask you to explain your claims? You are a cardiologist. People should be able to question your interpretation of a study without being insulted. If your evidence is as clear as you say, explain it properly, acknowledge the limitations of individual measurements and address the questions people are actually asking you. Repeating enormous numbers and insulting people is not a substitute for explaining the science. Go back to cardiology school.

Dr. Alo, where are you getting your claim that only 0.1% to 3% of patients experience statin side effects? The ACC/AHA guidelines report muscle symptoms in 1% to 5% of randomized trial participants and 5% to 10% in observational studies and clinical settings. A 2022 analysis involving more than 120,000 participants found that 27.1% of statin users and 26.6% of placebo recipients reported muscle pain or weakness. The difference matters because not every reported symptom is caused by statins, but your blanket statement does not accurately represent the evidence.
2022 American Heart Association scientific statement:
2022 Lancet analysis of statin therapy and muscle symptoms:
https://doi.org/10.1016/S0140-6736(22)01545-8 
You also claim that all adverse effects reverse when treatment stops. That is not accurate. Rare complications, including statin associated autoimmune necrotizing myopathy, can persist after discontinuation and require immunosuppressive treatment.
National Institutes of Health, Statin Associated Autoimmune Myopathy:
https://www.ncbi.nlm.nih.gov/books/NBK559279/ 
Why are you presenting selective figures and absolute reassurances instead of explaining the full evidence? Can you personally address these specific claims from your video, or will your automated AI continue generating responses on your behalf without directly answering the questions being asked?

If being wrong in medicine really means changing your position when the data demand it, then apply that standard consistently. You have repeatedly made claims that go beyond the evidence. You said KETO CTA showed that LDL was “the only thing that mattered,” even though that conclusion was not established by the study. You have told someone eating eggs and red meat that it was “probably plugging up” their arteries without knowing their ApoB, Lp(a), imaging, blood pressure, metabolic health or other major risk factors. You repeatedly presented LDL C as the central number, yet you now acknowledge that ApoB can provide important information beyond LDL C. You have described elevated LDL as if it explains the entire atherosclerotic disease process, when ASCVD involves multiple interacting causal and modifying factors. And you have publicly claimed that heart disease can be “completely eliminated,” which current evidence does not establish. Changing your position when better evidence appears is good medicine. Presenting conclusions more strongly than the evidence supports is the problem.

https://www.dralo.net/blog/apob

https://www.dralo.net/cholesterol-masterclass

https://www.dralo.net/podcasts/dr-alo-show